Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimal Change Disease”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Not applicableLooking for participantsNCT06490809
What this trial is testing

Minimal Clinically Important Difference of the Box and Block Test in Parkinson

Who this might be right for
Parkinson Disease
Emre Şenocak 44
Not applicableStudy completedNCT03251781
What this trial is testing

Minimal Important Difference for the Glittre-ADL Test and London Chest Activity of Daily Living Scale

Who this might be right for
Pulmonary Disease, Chronic Obstructive
University of the State of Santa Catarina 77
Large-scale testing (Phase 3)Study completedNCT04494438
What this trial is testing

Rituximab for Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic Syndrome
Istituto Giannina Gaslini 30
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Not applicableActive Not RecruitingNCT02194582
What this trial is testing

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more
Beth Israel Deaconess Medical Center 2,050
Not applicableStudy completedNCT02336100
What this trial is testing

Diagnostic Value of Flexible Spectral Imaging Color Enhancement (FICE) Plus Probe-based Confocal Laser Endomicroscopy (pCLE) for Minimal Change Esophageal Reflux Disease (MERD) Diagnosis

Who this might be right for
Gastroesophageal Reflux Disease
King Chulalongkorn Memorial Hospital 36
Not applicableActive Not RecruitingNCT06901921
What this trial is testing

Responsiveness and Minimal Clinically Important Difference (MCID) of Knee Injury and Osteoarthritis (KOOS-12) in (OA)

Who this might be right for
Knee Osteoarthritis
Superior University 60
Not applicableNot Yet RecruitingNCT06726135
What this trial is testing

The NRC Dataset. Developing a Minimum Dataset for Multidisciplinary Rehabilitation: a Modified E-Delphi Study

Who this might be right for
PainTraumatic Brain InjuryMajor Trauma+6 more
ThomasCorbett 50
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Not applicableNot Yet RecruitingNCT06978036
What this trial is testing

Endoscope-assisted Flapless Approach Versus Papillary Preservation Technique in Periodontal Regeneration.

Who this might be right for
PeriodontitisPeriodontal Regeneration, Clinical and Radiographic Results, Modified Minimal Invasive SurgeryPeriodontal Regeneration
The University of Hong Kong 56
Not applicableNot Yet RecruitingNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Not applicableUnknownNCT04366882
What this trial is testing

Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients

Who this might be right for
COVID-19
Jessa Hospital 48
Testing effectiveness (Phase 2)Study completedNCT02592798
What this trial is testing

Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Post-approval studies (Phase 4)Study completedNCT07023939
What this trial is testing

Atraumatic Versus Silver-Modified Atraumatic Restorative Treatment in Primary Molars

Who this might be right for
Dental CariesDental Caries in Children
Beirut Arab University 34
Not applicableStudy completedNCT02346279
What this trial is testing

Responsiveness and Minimal Clinical Important Difference of the Multiple Sclerosis Questionnaire for Physiotherapists

Who this might be right for
Multiple Sclerosis
Institut fuer Physiotherapieforschung 81
Testing effectiveness (Phase 2)Looking for participantsNCT06500702
What this trial is testing

Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi 84
Not applicableStudy completedNCT04603079
What this trial is testing

Nurse Leadership for Hospital Infection Control

Who this might be right for
Nurse's RoleInfection
Forman Christian College, Pakistan 344
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Large-scale testing (Phase 3)Looking for participantsNCT05914155
What this trial is testing

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome

Who this might be right for
Glomerulonephritis, MembranousNephrotic Syndrome,Idiopathic
Shoichi Maruyama MD PhD 88
Load More Results